Efficacy of olocizumab in treatment of COVID-19 patients

T. V. Goma; A. N. Kalyagin; O. V. Ryzhkova; N. S. Soloveva

Acta Biomedica Scientifica
Acta biomedica scientifica

ISSN 2541-9420 (Print)
ISSN 2587-9596 (Online)

User

eng | рус

Acta Biomedica Scientifica

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Goma T.V., Kalyagin A.N., Ryzhkova O.V., Soloveva N.S. Efficacy of olocizumab in treatment of COVID-19 patients. Acta Biomedica Scientifica. 2022;7(5-2):86-95. (In Russ.) https://doi.org/10.29413/ABS.2022-7.5-2.9

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2541-9420 (Print)
ISSN 2587-9596 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Kolesnikov S. I.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

T. V. Goma
Irkutsk State Medical University
Russian Federation

Tatyana V. Goma – Cand. Sc. (Med.), Teaching Assistant at the Department of Intermediate-Level Therapy

Krasnogo Vosstaniya str. 1, Irkutsk 664003

A. N. Kalyagin
Irkutsk State Medical University
Russian Federation

Alexey N. Kalyagin – Dr. Sc. (Med.), Professor, Head of the Department of Propedeutics of Internal Diseases

Krasnogo Vosstaniya str. 1, Irkutsk 664003

O. V. Ryzhkova
Irkutsk State Medical University
Russian Federation

Olga V. Ryzhkova – Dr. Sc. (Med.), Professor at the Department of Intermediate-Level Therapy

Krasnogo Vosstaniya str. 1, Irkutsk 664003

N. S. Soloveva
R-Pharm JSC
Russian Federation

Natalia S. Solovieva – Medical Adviser

Leninsky ave. 111 build. 1, Moscow 119427

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Acta Biomedica Scientifica

For citations:

Cookies policy